Life Science News

Latest updates from the biotech and pharma world

FierceBiotech 2026-01-26

Ex-CytoDyn CEO sentenced to prison, must pay $5.3M restitution as former CRO leader wins new trial

FierceBiotech 2026-01-26

European investment firm Gimv calls it quits on new life science financing

FierceBiotech 2026-01-26

New rules, higher stakes: Biopharma plays the long game in 2026

BioPharma Dive 2026-01-26

China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says

Endpoints News 2026-01-26

Ex-CytoDyn CEO sentenced to 30 months for pump-and-dump scheme

BioWorld 2026-01-26

Med-tech gainers and losers for Jan. 19-23, 2026

Endpoints News 2026-01-26

Catalent plans to close Belgium cell therapy site

BioWorld 2026-01-26

Financings for Jan. 26, 2026

BioWorld 2026-01-26

In the clinic for Jan. 26, 2026

BioWorld 2026-01-26

Other news to note for Jan. 26, 2026

BioWorld 2026-01-26

Regulatory actions for Jan. 26, 2026

BioPharma Dive 2026-01-26

Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time

Endpoints News 2026-01-26

Sarepta touts three-year Duchenne gene therapy data after patient deaths

FierceBiotech 2026-01-26

Feds charge former Zynex execs in massive medtech billing fraud case

FierceBiotech 2026-01-26

Guardant Health gets FDA nod to expand use of blood test for colon cancer

FierceBiotech 2026-01-26

AstraZeneca keeps UK research site on pause, but options open

FierceBiotech 2026-01-26

Fortitude has faith molecular glue degraders can overcome ADC resistance

Endpoints News 2026-01-26

Genyro licences DNA builder from Caltech; Dizal targets Hong Kong listing

BioWorld 2026-01-26

Biggest gainers and losers for Jan. 19-23, 2026

BioPharma Dive 2026-01-26

Biotech investor Cormorant secures $150M for another SPAC deal

-132 / 193